Cargando…
Enhanced therapeutic effects of mesenchymal stem cell-derived extracellular vesicles within chitosan hydrogel in the treatment of diabetic foot ulcers
Extracellular vesicles (EVs) derived from human umbilical cord mesenchymal stem cells (hUCMSCs) have emerged as promising candidates for cell-free therapy in various diseases, including chronic cutaneous wounds. However, the lack of standardized protocols for EVs’ preparation and identification pose...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462522/ https://www.ncbi.nlm.nih.gov/pubmed/37639051 http://dx.doi.org/10.1007/s10856-023-06746-y |
_version_ | 1785098050853666816 |
---|---|
author | Yang, Shuangshuang Chen, Siyu Zhang, Chengpeng Han, Jing Lin, Chunyuan Zhao, Xiaohui Guo, Huizhen Tan, Yi |
author_facet | Yang, Shuangshuang Chen, Siyu Zhang, Chengpeng Han, Jing Lin, Chunyuan Zhao, Xiaohui Guo, Huizhen Tan, Yi |
author_sort | Yang, Shuangshuang |
collection | PubMed |
description | Extracellular vesicles (EVs) derived from human umbilical cord mesenchymal stem cells (hUCMSCs) have emerged as promising candidates for cell-free therapy in various diseases, including chronic cutaneous wounds. However, the lack of standardized protocols for EVs’ preparation and identification poses a significant challenge to their clinical application. Thus, the objective was to develop a safe and efficient method for the large-scale production of hUCMSC-derived EVs while establishing a comprehensive identification protocol encompassing morphology, particle size distribution, protein expression, and purity. This study observed that most of the EVs acquired through the protocol exhibited either a cup-shaped or round-shaped structure, with a median diameter of ~73.25 nm. The proportions of EVs positive for CD9, CD63, and CD81 were 37.5%, 38.6%, and 19.8%, respectively. To enhance their therapeutic potential in wound treatment, EVs were incorporated into chitosan hydrogel, forming chitosan hydrogel-EVs (CS-EVs). Furthermore, it was demonstrated that CS-EVs exhibited continuous release of EVs into the surrounding environment and, importantly, that the released EVs were internalized by human umbilical vein endothelial cells (HUVECs), resulting in significant enhancement of cell migration and angiogenesis. Additionally, in a rat model of diabetic foot ulcers, CS-EVs demonstrated a robust therapeutic effect in promoting wound healing. Following a 15-day treatment period, the group treated with CS-EVs demonstrated an impressive 93.3% wound closure ability, accompanied by a high degree of re-epithelialization. In contrast, the control group exhibited only a 71.5% reduction in wound size. In summary, this study offers solutions for the purification, characterization, and application of EVs in clinical wound treatment. These results not only offer fresh perspectives on the involvement of hUCMSC-derived EVs in wound healing but also introduce a non-invasive approach for applying EVs that holds practical significance in skin repair. GRAPHICAL ABSTRACT: [Image: see text] |
format | Online Article Text |
id | pubmed-10462522 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Springer US |
record_format | MEDLINE/PubMed |
spelling | pubmed-104625222023-08-30 Enhanced therapeutic effects of mesenchymal stem cell-derived extracellular vesicles within chitosan hydrogel in the treatment of diabetic foot ulcers Yang, Shuangshuang Chen, Siyu Zhang, Chengpeng Han, Jing Lin, Chunyuan Zhao, Xiaohui Guo, Huizhen Tan, Yi J Mater Sci Mater Med Tissue Engineering Constructs and Cell Substrates Extracellular vesicles (EVs) derived from human umbilical cord mesenchymal stem cells (hUCMSCs) have emerged as promising candidates for cell-free therapy in various diseases, including chronic cutaneous wounds. However, the lack of standardized protocols for EVs’ preparation and identification poses a significant challenge to their clinical application. Thus, the objective was to develop a safe and efficient method for the large-scale production of hUCMSC-derived EVs while establishing a comprehensive identification protocol encompassing morphology, particle size distribution, protein expression, and purity. This study observed that most of the EVs acquired through the protocol exhibited either a cup-shaped or round-shaped structure, with a median diameter of ~73.25 nm. The proportions of EVs positive for CD9, CD63, and CD81 were 37.5%, 38.6%, and 19.8%, respectively. To enhance their therapeutic potential in wound treatment, EVs were incorporated into chitosan hydrogel, forming chitosan hydrogel-EVs (CS-EVs). Furthermore, it was demonstrated that CS-EVs exhibited continuous release of EVs into the surrounding environment and, importantly, that the released EVs were internalized by human umbilical vein endothelial cells (HUVECs), resulting in significant enhancement of cell migration and angiogenesis. Additionally, in a rat model of diabetic foot ulcers, CS-EVs demonstrated a robust therapeutic effect in promoting wound healing. Following a 15-day treatment period, the group treated with CS-EVs demonstrated an impressive 93.3% wound closure ability, accompanied by a high degree of re-epithelialization. In contrast, the control group exhibited only a 71.5% reduction in wound size. In summary, this study offers solutions for the purification, characterization, and application of EVs in clinical wound treatment. These results not only offer fresh perspectives on the involvement of hUCMSC-derived EVs in wound healing but also introduce a non-invasive approach for applying EVs that holds practical significance in skin repair. GRAPHICAL ABSTRACT: [Image: see text] Springer US 2023-08-28 2023 /pmc/articles/PMC10462522/ /pubmed/37639051 http://dx.doi.org/10.1007/s10856-023-06746-y Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . |
spellingShingle | Tissue Engineering Constructs and Cell Substrates Yang, Shuangshuang Chen, Siyu Zhang, Chengpeng Han, Jing Lin, Chunyuan Zhao, Xiaohui Guo, Huizhen Tan, Yi Enhanced therapeutic effects of mesenchymal stem cell-derived extracellular vesicles within chitosan hydrogel in the treatment of diabetic foot ulcers |
title | Enhanced therapeutic effects of mesenchymal stem cell-derived extracellular vesicles within chitosan hydrogel in the treatment of diabetic foot ulcers |
title_full | Enhanced therapeutic effects of mesenchymal stem cell-derived extracellular vesicles within chitosan hydrogel in the treatment of diabetic foot ulcers |
title_fullStr | Enhanced therapeutic effects of mesenchymal stem cell-derived extracellular vesicles within chitosan hydrogel in the treatment of diabetic foot ulcers |
title_full_unstemmed | Enhanced therapeutic effects of mesenchymal stem cell-derived extracellular vesicles within chitosan hydrogel in the treatment of diabetic foot ulcers |
title_short | Enhanced therapeutic effects of mesenchymal stem cell-derived extracellular vesicles within chitosan hydrogel in the treatment of diabetic foot ulcers |
title_sort | enhanced therapeutic effects of mesenchymal stem cell-derived extracellular vesicles within chitosan hydrogel in the treatment of diabetic foot ulcers |
topic | Tissue Engineering Constructs and Cell Substrates |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10462522/ https://www.ncbi.nlm.nih.gov/pubmed/37639051 http://dx.doi.org/10.1007/s10856-023-06746-y |
work_keys_str_mv | AT yangshuangshuang enhancedtherapeuticeffectsofmesenchymalstemcellderivedextracellularvesicleswithinchitosanhydrogelinthetreatmentofdiabeticfootulcers AT chensiyu enhancedtherapeuticeffectsofmesenchymalstemcellderivedextracellularvesicleswithinchitosanhydrogelinthetreatmentofdiabeticfootulcers AT zhangchengpeng enhancedtherapeuticeffectsofmesenchymalstemcellderivedextracellularvesicleswithinchitosanhydrogelinthetreatmentofdiabeticfootulcers AT hanjing enhancedtherapeuticeffectsofmesenchymalstemcellderivedextracellularvesicleswithinchitosanhydrogelinthetreatmentofdiabeticfootulcers AT linchunyuan enhancedtherapeuticeffectsofmesenchymalstemcellderivedextracellularvesicleswithinchitosanhydrogelinthetreatmentofdiabeticfootulcers AT zhaoxiaohui enhancedtherapeuticeffectsofmesenchymalstemcellderivedextracellularvesicleswithinchitosanhydrogelinthetreatmentofdiabeticfootulcers AT guohuizhen enhancedtherapeuticeffectsofmesenchymalstemcellderivedextracellularvesicleswithinchitosanhydrogelinthetreatmentofdiabeticfootulcers AT tanyi enhancedtherapeuticeffectsofmesenchymalstemcellderivedextracellularvesicleswithinchitosanhydrogelinthetreatmentofdiabeticfootulcers |